← Evidence map

ArticleBMC nephrology2025

Serum ALCAM is a potential novel non-invasive marker for predicting the progression of IgA nephropathy.

Zengyuan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41466192